Powerful as individual solution – Unstoppable together
The new ZEISS Cataract Workflow
By connecting devices, data and applications, the ZEISS portfolio enables a seamless integration from office to OR and back.
Based on 20+ years experience, development and production, ZEISS provides a state-of-the-art ophthalmic viscosurgical devices (OVD) portfolio that supports your work at each step of the ophthalmic procedure. ZEISS OVDs originate from bacterial fermentation.1
Preoperative topical ampules containing sodium hyaluronate (0.3%) with lidocaine (2%) that coats and hydrates the epithelial cells supporting clear vision into the eye.
Intracameral viscous-cohesive OVD
Providing the optimal combination of a viscous-cohesive and a medium-viscosity dispersive OVD in two separate syringes. Giving you the space and protection you need in standard and complex cases – with fast and easy removal.
Cohesive part (incl. Z-HYALIN®plus)
Dispersive part (incl. Z-HYALCOAT®)
Combining a medium-viscosity dispersive and a viscous-cohesive viscoelastic in one syringe separated by an innovative bypass stopper system for a planned sequential injection. Providing an easy and unique approach to the soft-shell-technique.8
ZEISS OVDs available in 10 syringe multipacks:
Classification
|
Single pack content
|
Multipack content
|
Origin
|
Volume (ml)
|
Substance
|
Concentration I (%)
|
Concentration II (mg/ml)
|
|
---|---|---|---|---|---|---|---|---|
VISTHESIA 1.0%
|
Viscous-cohesive
|
1 x intracameral syringe
|
Bacterial fermentation
|
0.8
|
Sodium Hyaluronate
|
1.0
|
10
|
|
1 x 27 G cannula
|
Lidocaine
|
1.0
|
10
|
|||||
2 x topical ampules (see below*)
|
Hydrochloride
|
|||||||
VISTHESIA 1.5%
|
Viscous-cohesive
|
1 x intracameral syringe
|
Bacterial fermentation
|
0.8
|
Sodium Hyaluronate
|
1.5
|
15
|
|
1 x 27 G cannula
|
Lidocaine
|
1.0
|
10
|
|||||
2 x topical ampules (see below*)
|
Hydrochloride
|
|||||||
*VISTHESIA topical ampule11
|
n/a
|
2 x topical ampules
|
Bacterial fermentation
|
2 x 0.3
|
Sodium Hyaluronate
|
2 x 0.3
|
2 x 3
|
|
Lidocaine
|
2.0
|
20
|
||||||
Hydrochloride
|
||||||||
VISTHESIA 1.0% intra12
|
Viscous-cohesive
|
1 x intracameral syringe
|
Bacterial fermentation
|
0.8
|
Sodium Hyaluronate
|
1.0
|
10
|
|
1 x 27 G cannula
|
Lidocaine
|
1.0
|
10
|
|||||
Hydrochloride
|
||||||||
VISTHESIA 1.5% intra12
|
Viscous-cohesive
|
1 x intracameral syringe
|
Bacterial fermentation
|
0.8
|
Sodium Hyaluronate
|
1.5
|
15
|
|
1 x 27 G cannula
|
Lidocaine
|
1.0
|
10
|
|||||
Hydrochloride
|
||||||||
All OVDs are phthalate free and have a pH range between 6.8 and 7.6.
The shelf life for all OVDs is 3 years except for TWINVISC, which has a shelf life of 2 years
Classification
|
Single pack content
|
Multipack content
|
Origin
|
Volume (ml)
|
Substance
|
Concentration I (%)
|
Concentration II (mg/ml)
|
|
---|---|---|---|---|---|---|---|---|
COMBIVISC
|
Viscous-cohesive
|
1 x intracameral syringe
|
5 x intracameral syringes
|
Bacterial fermentation
|
1.0
|
Sodium Hyaluronate
|
1.5
|
15
|
1 x 25 G cannulas
|
5 x 25 G cannulas
|
|||||||
Medium-viscosity dispersive
|
1 x intracameral syringes
|
5 x intracameral syringes
|
Bacterial fermentation
|
0.85
|
Sodium Hyaluronate
|
3.0
|
30
|
|
1 x 25 G cannula
|
5 x 25 G cannulas
|
|||||||
TWINVISC
|
Medium-viscosity dispersive
|
1 x two-chamber intracameral syringe
|
-
|
Bacterial fermentation
|
0.7
|
Sodium Hyaluronate
|
2.2
|
22
|
1 x 25 G cannula
|
||||||||
Viscous-cohesive
|
1 x two-chamber intracameral syringe
|
-
|
Bacterial fermentation
|
0.7
|
Sodium Hyaluronate
|
1.0
|
10
|
|
1 x 25 G cannula
|
||||||||
All OVDs are phthalate free and have a pH range between 6.8 and 7.6.
The shelf life for all OVDs is 3 years except for TWINVISC, which has a shelf life of 2 years
Classification
|
Single pack content
|
Multipack content
|
Origin
|
Volume (ml)
|
Substance
|
Concentration I (%)
|
Concentration II (mg/ml)
|
|
---|---|---|---|---|---|---|---|---|
Z-CELCOAT
|
Low-viscosity dispersive
|
1 x intracameral syringe
|
10 x intracameral syringes
|
Botanical
|
2.1
|
Hydroxypropyl-methylcellulose
|
2.0
|
20
|
1 x 23 G cannula
|
10 x 23 G cannulas
|
|||||||
Z-HYALCOAT
|
Medium-viscosity dispersive
|
1 x intracameral syringe
|
10 x intracameral syringes
|
Bacterial fermentation
|
0.85
|
Sodium Hyaluronate
|
3.0
|
30
|
1 x 25 G cannula
|
10 x 25 G cannulas
|
|||||||
All OVDs are phthalate free and have a pH range between 6.8 and 7.6.
The shelf life for all OVDs is 3 years except for TWINVISC, which has a shelf life of 2 years
Classification
|
Single pack content
|
Multipack content
|
Origin
|
Volume (ml)
|
Substance
|
Concentration I (%)
|
Concentration II (mg/ml)
|
|
---|---|---|---|---|---|---|---|---|
Z-HYALIN
|
Viscous-cohesive
|
1 x intracameral syringe
|
10 x intracameral syringes
|
Bacterial fermentation
|
1.0
|
Sodium Hyaluronate
|
1.0
|
10
|
1 x 27 G cannula
|
10 x 27 G cannulas
|
|||||||
Z-HYALIN plus
|
Viscous-cohesive
|
1 x intracameral syringe
|
10 x intracameral syringes
|
Bacterial fermentation
|
1.0
|
Sodium Hyaluronate
|
1.5
|
15
|
1 x 27 G cannula
|
10 x 27 G cannulas
|
|||||||
Z-HYALON
|
Viscous-cohesive
|
10 x intracameral syringes |
10 x intracameral syringes |
Rooster comb
|
0.55 or 0.85
|
Sodium Hyaluronate
|
1.0
|
10
|
10 x 27 G cannulas |
10 x 27 G cannulas |
|||||||
Z-HYALON plus
|
Super-viscous cohesive
|
1 x intracameral syringe
|
-
|
Rooster comb
|
0.55 |
Sodium Hyaluronate
|
1.4
|
14
|
1 x 27 G cannula
|
||||||||
All OVDs are phthalate free and have a pH range between 6.8 and 7.6.
The shelf life for all OVDs is 3 years except for TWINVISC, which has a shelf life of 2 years
Except: Z-HYALON, Z-HYALON plus, Z-CELCOAT
VISTHESIA 1.0% and VISTHESIA 1.5% are not for sale in the UK or Portugal
F. Poyales-Galan, G. Pirazzoli: Clinical Evaluation of Endothelial Cell Decrease with VISTHESIA In: Phacoemulsification Surgery. JCRS Vol. 31, Nov. 2005
S. K. Pandey et al.: Evaluation of the cataractgenic effect of viscoanesthetic solutions on the rabbit crystalline lens. JCRS Vol. 31, July 2005
Harry Domack: Z-HYALIN Plus: A Versatile Cohesive Agent. Cataract & Refractive Surgery Today, Europe, July/August 2011
S. A. Arshinoff, M Jafari: New classification of ophthalmic viscosurgical devices. JCRS Vol. 31, Nov. 2005
W. W. Hütz et al.: Comparison of viscoelastic substances used in phacoemulsification. JCRS Vol. 22, Sept. 1996
ZEISS: TWINVISC – Two OVDs, one syringe, a unique concept (User testimonial by S. Arshinoff), 2011
G. U. Auffahrt et al.: Comparison of the performance and safety of 2 ophthalmic viscosurgical devices in cataract surgery. JCRS Vol. 43, Jan. 2017
A. D. Steele, V. Andrews: Methylcellulose for endothelial cell protection. Australian and New Zealand Journal of Ophthalmology Vol. 16, 1988
Not available individually; only available with VISTHESIA 1.0% or 1.5%
VISTHESIA intra version does not contain 2 topical ampules
Megadalton = 1 million Dalton
1Pa s = 1000 mPa s